{"id":"NCT00076050","sponsor":"University of Miami","briefTitle":"Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms","officialTitle":"Bone Sparing Effects of Soy Phytoestrogens in Menopause","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-09","primaryCompletion":"2009-03","completion":"2009-06","firstPosted":"2004-01-14","resultsPosted":"2016-12-06","lastUpdate":"2016-12-06"},"enrollment":248,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Menopause","Osteoporosis","Osteopenia"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Soy isoflavones","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if soy-derived phytoestrogens (naturally occurring compounds similar to estrogen) can prevent bone loss and other menopausal symptoms in women who have recently gone through menopause.\n\nStudy hypothesis: Tablets of high-dose, purified soy phytoestrogens spare the normally occurring spinal bone loss and improve biological and other emotional changes of menopause.","primaryOutcome":{"measure":"Change From Baseline in Bone Mineral Density","timeFrame":"baseline and 2 years","effectByArm":[{"arm":"Soy Isoflavone Group","deltaMin":1.146,"sd":0.125},{"arm":"Placebo Group","deltaMin":1.132,"sd":0.124}],"pValues":[]},"eligibility":{"minAge":"45 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21824950"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":122},"commonTop":["abdominal bloating","headache","hair loss","dry mouth","constipation"]}}